WHC is still in active development. Read this to understand our approach.
depiction of VYFYYTLLBUKUHU-UHFFFAOYSA-N.svg
isomerdesign

Dopamine

Verificar en isomerdesign

pubchem

Dopamine

Verificar en pubchem

drugmap

Dopamine

Verificar en drugmap

wiki

Dopamine (medication...

Verificar en wiki

wiki

Dopamine

Verificar en wiki

Data

InChI: InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2

Sinónimos: KBio2_005052,NCGC00096050-03, Dopamine [INN:BAN],153C5321-5FEE-4B0B-8925-F388F0EEEBD1,2-(3, 4-Dihydroxyphenyl)ethylamine, 4-(2-Aminoethyl)pyrocatechol, LDP,IP 498,FT-0698513,DOPAMINE [HSDB],NSC173182,4-(2-Aminoethyl)-1,2-benzenediol, Dopaminum [INN-Latin], 4-(2-Aminoethyl)-1,2-bezenediol,KBio3_002962,4-(2-Aminoethyl)catechol,LDP,BDBM55121,4-(2-Aminoethyl)-1,2-benzenediol #,SBI-0050568.P004,Oxytyramine,1,2-Benzenediol, 4-(2-aminoethyl)- (9CI), IP 498,Tox21_110167,Dopamine (INN),Spectrum5_000945,NCGC00096050-02, Pyrocatechol, 4-(2-aminoethyl)-(8CI), 2-benzenediol,FS-5341,DSSTox_RID_76584,Dynatra,4-(2-Aminoethyl)-1,2-benzenediol hydrochloride,DB00988, 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI),3-Hydroxytyramine,KBio1_000780,UNII-VTD58H1Z2X,EN300-35022,KBioSS_001492, Dopamine (INN),dopamine,4-(2-aminoethyl)-pyrocatechol, Intropin, KW-3-060, 4-(2-Aminoethyl)pyrocatechol hydrochloride,KBio3_002867,KBio3_001152,AB00053463-12,NCGC00015519-10,ZINC33882,4-(2-azanylethyl)benzene-1,2-diol;hydrochloride,Q170304,cMAP_000065,CCG-204675, ASL 279,Dopamine [INN:BAN],NCGC00015519-08,NCGC00015519-11, 3,4-Dihydroxyphenethylamine hydrochloride,KBio2_007524,2-(3,4-dihydroxyphenyl)ethylamine,KBio2_007620,Dopamine (USAN)(*hydrochloride*),Dobutamine a,Intropin (Salt/Mix), Oxytyramine,Dopaminum,KBio2_002388,3-Hydroxtyramine,DOBUTAMINE HYDROCHLORIDE IMPURITY A [EP IMPURITY],.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane,KBio2_001492,Spectrum4_000525,UPCMLD0ENAT5885989:001,Pyrocatechol, 4-(2-aminoethyl)-,hydroxytyramine,NCGC00096050-01, 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium,NCGC00096050-05, Dopaminum,BCP34189,EINECS 200-110-0, 3,4-dihydroxyphenethylamine,4-(2-Aminoethyl)benzene-1,2-diol,DSSTox_GSID_22420,3,4-dihydroxyphenethylamine,HSDB 3068,.beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride,cMAP_000036,50444-17-2,AMY40803,Spectrum3_000406, Hydroxytyramine,BBL013043,m-Hydroxytyramine-,NCGC00015519-05,NCGC00096050-04,NSC169105, 3-Hydroxytyramine hydrochloride,3,4-DihydroxyphenylA currencythylamin, Dopamina [INN-Spanish],VTD58H1Z2X,4-(2-Aminoethyl)pyrocatechol,DSSTox_CID_2420,BIDD:ER0506,Sinemet,NSC-173182,L-DOPAMINE,4-(2-aminoethyl)pyrocatechol;hydrochloride, Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride, 3-Hydroxytyramine Hydrobromide,Spectrum2_001023,Oprea1_088821,A-dopamine,Biomol-NT_000001, Revimine,SDCCGSBI-0050568.P005,Dopamine,1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium,Dopaminum [INN-Latin],NCGC00015519-04, 4-(2-Aminoethyl)benzene-1,2-diol, Dophamine, 2-(3,4-dihydroxyphenyl)ethylamine, L-DOPAMINE,(3H)-Dopamine,4-(2-Amino-ethyl)-benzene-1,2-diol,F21485,Intropin [*hydrochloride*],KBio2_004060,SR-01000075366-7,SPECTRUM1505155,Spectrum_001012, 4-(2-aminoethyl)-pyrocatechol, 4-(2-Aminoethyl)-1, 153C5321-5FEE-4B0B-8925-F388F0EEEBD1,1,2-Benzenediol, 4-(2-aminoethyl)-,cid_65340,51-61-6,DivK1c_000780, A-(3,4-Dihydroxyphenyl)-b-aminoethane,62-31-7 (HYDROCHLORIDE),Dophamine,Dopamin,KBioGR_002388,NCGC00015519-01,NCGC00015519-03,DOBUTAMINE HYDROCHLORIDESPECIFIED IMPURITY A [EP IMPURITY], Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane,BP-23276,L000232, 4-(2-Aminoethyl)catechol, Intropin [*hydrochloride*],3,4-Dihydroxyphenylethylamine,KBioGR_002484,KBio2_006628, M-Hydroxytyramine hydrochloride,alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane, 4-(2-Aminoethyl)-1,2-benzenediol,3,4-Dihydroxyphenethylamine,2-(4-Hydroxy-5-oxylatophenyl)-1-ethanaminium,Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride,4-(2-Aminoethyl)-1,2-bezenediol,KBio2_002484,Lopac0_000586,Medopa (TN), Medopa (TN),bmse000933,IDI1_000780,CAS-51-61-6, Dopamine (USAN)(*hydrochloride*),DOPAMINE [VANDF],C03758,KBioSS_002491,2-(3,4-dihydroxyphenyl) ethylamine,86389-83-5,KBioGR_001129,STK301601,1, 4-(2-aminoethyl)-,Tox21_110167_1,Oseltamivir-d3;Hydroxytyramin;4-(2-Aminoethyl)benzene-1,2-diol,DOPAMINE [INN],NINDS_000780, Hydroxytyramin,KBio2_004956,NCGC00015519-09,DOPAMINE [WHO-DD],2-(3,4-Dihydroxyphenyl)-1-ethanamine,1,2-Benzenediol, 4-(2-aminoethyl)-, homopolymer,HMS3743I03,NORADRENALINE TARTRATE IMPURITY C [EP IMPURITY],DTXSID6022420, Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride, 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride,Lopac-H-8502,intropin,a-(3,4-Dihydroxyphenyl)-b-aminoethane,Hydroxytyramin, Dopamina,Pyrocatechol, 4-(2-aminoethyl)- (8CI),NCGC00015519-02,NSC 173182, 3-Hydroxytyramine,DOPAMINE [MI],BSPBio_001932,NCGC00015519-25,CHEMBL59,bmse000909, 3,4-Dihydroxyphenylethylamine,SPBio_001205,CHEBI:18243,AKOS003790978, 3-Hydroxtyramine,GTPL940,NCGC00015519-07,ASL 279,KBioSS_002393,BPBio1_001123,D07870, (3H)-Dopamine,KW-3-060,Dopamina,MFCD00130258,SCHEMBL8505,SR-01000075366,AB00053463_13,AB00053463_14,Dopamina [INN-Spanish]

Estimated data

Solubilidad: -0.688 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 73.8% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.